Due to their expression of the Fc gamma receptor (FcγR) CD16A, NK cells can also contribute to the anti-tumour functions of certain monoclonal antibodies (mAbs) via antibody dependent cellular cytotoxicity (ADCC) (2). Here, FCGR3A is linked to neoplasm.